Phlorophenone derivatives, processes for preparing such compounds, uses and pharmaceutical compositions of phlorophenone compounds
申请人:NORISTAN LIMITED
公开号:EP0069536A1
公开(公告)日:1983-01-12
Novel compounds of general formula I
wherein R is a branched or unbranched alkyl, cycloalkyl, or aralkyl group, which group optionally contains or is substituted by a halogen or oxygen function, the oxygen function optionally being in the form of an alcohol or ether moiety;
R1, R2, and R3 which may be the same of different, is hydrogen, an alkyl, acyl, or benzoyl group, which group optionally contains or is substituted by a halogen or oxygen function;
R4 is hydrogen, an alkyl, alkenyl preferably being an allyl or prenyl group, or aralkyl group which group optionally contains or is substituted by an alkyl, aryl, halogen or oxygen function;
R5 is hydrogen, an alkyl, aralkyl, acyl, or aryl group which group optionally contains or is substituted by an alkyl, aryl, halogen, or oxygen function; except that R4 and R5 are not both hydrogen; and except for the compounds when R5 is hydrogen and R is methyl, i-propyl, branched butyl, methoxy methyl, 2-phenylethyl, or 2-phenylethylene;
chromans and dihydrobenzofurans derived from these compounds;
pharmaceutically acceptable salts, and metabolites and metabolic precursors of these compounds;
processes for preparing the aforementioned types of compounds; use of the aforementioned types of compounds as antibacterial and or antimycotic agents;
and pharmaceutical compositions of such compounds
通式 I 的新型化合物
其中 R 是支链或非支链烷基、环烷基或芳烷基,该基团可选择含有或被卤素或氧官能团取代,氧官能团可选择以醇或醚分子的形式存在;
R1、R2 和 R3(可以相同或不同)是氢、烷基、酰基或苯甲酰基,该基团可选择含有卤素或氧官能团或被卤素或氧官能团取代;
R4 是氢、烷基、烯基(最好是烯丙基或炔基)或芳烷基,其基团可选择含有或被烷基、芳基、卤素或氧官能团取代;
R5 是氢、烷基、芳烷基、酰基或芳基,其基团可选择包含或被烷基、芳基、卤素或氧官能团取代;但 R4 和 R5 不能都是氢;R5 为氢且 R 为甲基、一丙基、支链丁基、甲氧基甲基、2-苯基乙基或 2-苯基乙烯的化合物除外;
由这些化合物衍生的铬烷和二氢苯并呋喃;
药学上可接受的盐,以及这些化合物的代谢物和代谢前体;
上述类型化合物的制备工艺;上述类型化合物作为抗菌剂和或抗霉菌剂的用途;
以及此类化合物的药物组合物